Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
- Resource Type
- Article
- Authors
- Azria, David; Briers, Erik; Chang-Claude, Jenny; Choudhury, Ananya; Dunning, Alison; Elliott, Rebecca M; Gutiérrez-Enríquez, Sara; Rancati, Tiziana; Rattay, Tim; Rosenstein, Barry S.; De Ruysscher, Dirk; Seibold, Petra; Sperk, Elena; Paul Symonds, R; Stobart, Hilary; Talbot, Christopher J.; Vega, Ana; Veldeman, Liv; Ward, Tim; Webb, Adam; West, Catharine M.; Kerns, Sarah L.; Amidon Morlang, Ashley; Lee, Sharon M.; Peterson, Derick R.; Marples, Brian; Zhang, Hong; Bylund, Kevin; Rosenzweig, Doug; Hall, William; De Ruyck, Kim; Stock, Richard G.; Gómez-Caamaño, Antonio; Sosa-Fajardo, Paloma; Taboada-Valladares, Begoña; Aguado-Barrera, Miguel E.; Parker, Chris; Fonteyne, Valérie; Bultijnck, Renée; Symonds, R. Paul; Johnson, Kerstie; Lambrecht, Maarten; de Ruysscher, Dirk; Vanneste, Ben; Elliott, Rebecca M.; Herskind, Carsten; Veldwijk, Marlon R.; Avuzzi, Barbara; Valdagni, Riccardo; Farcy Jacquet, Marie-Pierre; West, Catharine; Janelsins, Michelle; Chen, Yuhchyau; Messing, Edward; Morrow, Gary
- Source
- In Radiotherapy and Oncology March 2022 168:75-82
- Subject
- Language
- ISSN
- 0167-8140